Hillevax Inc (HLVX)

$2.06 -0.05 (-2.37%)
Market Cap 105.80M
Revenue (ttm) 0.00
Net Income (ttm) -147.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 59,400
Avg Vol 326,818
Day's Range N/A - N/A
Shares Out 50.14M
Stochastic %K 79%
Beta 0.76
Analysts Hold
Price Target $1.92

Company Profile

HilleVax, Inc., a clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. It has a license agreement with Takeda Vaccines, Inc. to develop and commercialize HIL-214 pharmaceutical products. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in Febr...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 213 5054
Address:
321 Harrison Avenue, 5th Fl., Boston, United States
warpdrive1
warpdrive1 Jun. 4 at 2:09 PM
$HLVX strategic alternatives incoming
0 · Reply
WAYWARD_SUN
WAYWARD_SUN May. 19 at 2:41 PM
$HLVX
0 · Reply
joe77w
joe77w May. 8 at 1:19 PM
$HLVX 10Q out 3 usd in net equity https://www.otcmarkets.com/filing/html?id=18445085&guid=eeV-kFzAdOPedth
0 · Reply
PenkeTrading
PenkeTrading May. 1 at 12:48 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Hillevax Inc. Is that bullish or bearish? $HLVX #Hillevax #RsiOverbought #NASDAQ
0 · Reply
JarvisFlow
JarvisFlow Mar. 31 at 11:00 AM
HC Wainwright & Co. has updated their rating for HilleVax ( $HLVX ) to Neutral with a price target of 2.
0 · Reply
d_risk
d_risk Mar. 30 at 5:22 PM
$HLVX - HilleVax Inc. Common Stock - 10K - Updated Risk Factors HLVX's 2025 10-K Risk Factors highlight a strategic pivot from HIL-214 to broader norovirus vaccine candidates, emphasizing regulatory, patent, and commercialization challenges, workforce reductions, and increased reliance on third-party collaborations. New risks include potential Nasdaq delisting and geopolitical impacts on trade. #Biotechnology #GeopoliticalFactors #MarketCompetition #RegulatoryRisks #VaccineDevelopment 🟢 Added 🟠 Removed https://d-risk.ai/HLVX/10-K/2025-03-28
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 21 at 6:10 PM
$HLVX Tough break for HLVX. Norovirus vaccine miss is brutal. Might see some consolidation before potential pivot. Adult trial could be interesting play. Watching closely for strategic moves. solid article: https://beyondspx.com/article/hillevax-hlvx-navigating-the-challenges-of-norovirus-vaccine-development
0 · Reply
sivagnanam
sivagnanam Feb. 13 at 4:12 AM
$HLVX in
0 · Reply
TrendSetter67
TrendSetter67 Jan. 4 at 9:55 PM
$VXRT After reading this publication on enterics, how can $MRNA believe they will perform well with their Norovirus vaccine? They are on the same failed track as $HLVX. You can't protect against an intestinal virus with a needle in the arm. Oral/pill directly into the gut is the WAY. 💊 https://pmc.ncbi.nlm.nih.gov/articles/PMC9257994/
0 · Reply
Suh420
Suh420 Jan. 3 at 1:46 AM
$HLVX at Massive Key Breakout Level right now! $NIRO $QNCCF
0 · Reply
Latest News on HLVX
HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

May 8, 2025, 7:00 AM EDT - 2 months ago

HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

Frazier Life Sciences Appoints Aditya Kohli to Partner

Apr 17, 2025, 8:00 AM EDT - 2 months ago

Frazier Life Sciences Appoints Aditya Kohli to Partner

PHAT

HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress

Mar 28, 2025, 5:00 PM EDT - 3 months ago

HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress

HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

Aug 8, 2024, 7:20 PM EDT - 11 months ago

HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

Stakeholders Of HilleVax Inc Are Encouraged By The Schall Law Firm To Join The Alleged Securities Fraud Investigation

Jul 30, 2024, 9:00 AM EDT - 1 year ago

Stakeholders Of HilleVax Inc Are Encouraged By The Schall Law Firm To Join The Alleged Securities Fraud Investigation

Stakeholders Of HilleVax Inc Are Urged By The Schall Law Firm To Participate In The Alleged Securities Fraud Investigation

Jul 29, 2024, 3:30 PM EDT - 1 year ago

Stakeholders Of HilleVax Inc Are Urged By The Schall Law Firm To Participate In The Alleged Securities Fraud Investigation

Stakeholders Of Hillevax Inc Are Encouraged By The Schall Law Firm To Join The Alleged Securities Fraud Investigation

Jul 26, 2024, 3:15 PM EDT - 1 year ago

Stakeholders Of Hillevax Inc Are Encouraged By The Schall Law Firm To Join The Alleged Securities Fraud Investigation

Stakeholders Of HilleVax Inc Are Encouraged By The Schall Law Firm To Participate In The Alleged Securities Fraud Investigation

Jul 19, 2024, 3:15 PM EDT - 1 year ago

Stakeholders Of HilleVax Inc Are Encouraged By The Schall Law Firm To Participate In The Alleged Securities Fraud Investigation

HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Jul 19, 2024, 11:00 AM EDT - 1 year ago

HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

HLVX Investors Are Invited By The Schall Law Firm To Join Its Investigation Into Alleged Securities Fraud At HilleVax Inc.

Jul 18, 2024, 3:30 PM EDT - 1 year ago

HLVX Investors Are Invited By The Schall Law Firm To Join Its Investigation Into Alleged Securities Fraud At HilleVax Inc.

The Schall Law Firm Invites HLVX Investors To Participate In Its Investigation Of Alleged Securities Fraud At HilleVax Inc

Jul 17, 2024, 2:15 PM EDT - 1 year ago

The Schall Law Firm Invites HLVX Investors To Participate In Its Investigation Of Alleged Securities Fraud At HilleVax Inc

HLVX Investors Are Welcomed By The Schall Law Firm To Join Its Inquiry Into Suspected Securities Fraud At HilleVax Inc

Jul 16, 2024, 1:45 PM EDT - 1 year ago

HLVX Investors Are Welcomed By The Schall Law Firm To Join Its Inquiry Into Suspected Securities Fraud At HilleVax Inc

The Schall Law Firm Invites HLVX Stakeholders To Participate In Its Investigation Of Alleged Securities Fraud At HilleVax Inc

Jul 15, 2024, 2:15 PM EDT - 1 year ago

The Schall Law Firm Invites HLVX Stakeholders To Participate In Its Investigation Of Alleged Securities Fraud At HilleVax Inc

The Schall Law Firm Encourages HLVX Stakeholders To Join Its Probe Into Suspected Securities Fraud At HilleVax Inc

Jul 13, 2024, 5:00 PM EDT - 1 year ago

The Schall Law Firm Encourages HLVX Stakeholders To Join Its Probe Into Suspected Securities Fraud At HilleVax Inc

The Schall Law Firm Invites HLVX Stakeholders To Participate In Its Investigation Into Alleged Securities Fraud At HilleVax Inc

Jul 12, 2024, 5:40 PM EDT - 1 year ago

The Schall Law Firm Invites HLVX Stakeholders To Participate In Its Investigation Into Alleged Securities Fraud At HilleVax Inc

Stakeholders Of HLVX Are Urged To Join The Schall Law Firm's Investigation Of Securities Fraud At HilleVax Inc

Jul 11, 2024, 1:00 PM EDT - 1 year ago

Stakeholders Of HLVX Are Urged To Join The Schall Law Firm's Investigation Of Securities Fraud At HilleVax Inc

HLVX Stakeholders Are Encouraged To Participate In The Securities Fraud Investigation Of HilleVax Inc Led By The Schall Law Firm

Jul 10, 2024, 1:45 PM EDT - 1 year ago

HLVX Stakeholders Are Encouraged To Participate In The Securities Fraud Investigation Of HilleVax Inc Led By The Schall Law Firm

HLVX Stakeholders Are Invited To Join The HilleVax Inc Securities Fraud Probe Conducted By The Schall Law Firm

Jul 9, 2024, 2:00 PM EDT - 1 year ago

HLVX Stakeholders Are Invited To Join The HilleVax Inc Securities Fraud Probe Conducted By The Schall Law Firm

Gold Falls Over 1%; HilleVax Shares Plunge

Jul 8, 2024, 2:31 PM EDT - 1 year ago

Gold Falls Over 1%; HilleVax Shares Plunge

Investors In HLVX Can Participate In The Securities Fraud Investigation Of HilleVax Inc With The Schall Law Firm

Jul 8, 2024, 12:30 PM EDT - 1 year ago

Investors In HLVX Can Participate In The Securities Fraud Investigation Of HilleVax Inc With The Schall Law Firm

HLVX Investors Have Opportunity to Join HilleVax, Inc. Securities Fraud Investigation with the Schall Law Firm

Jul 8, 2024, 12:10 PM EDT - 1 year ago

HLVX Investors Have Opportunity to Join HilleVax, Inc. Securities Fraud Investigation with the Schall Law Firm

Vaccine Developer HilleVax Stock Nosedives On Monday - Here's Why

Jul 8, 2024, 9:43 AM EDT - 1 year ago

Vaccine Developer HilleVax Stock Nosedives On Monday - Here's Why

HilleVax shares plummet after norovirus vaccine fails in mid-stage study

Jul 8, 2024, 9:33 AM EDT - 1 year ago

HilleVax shares plummet after norovirus vaccine fails in mid-stage study

warpdrive1
warpdrive1 Jun. 4 at 2:09 PM
$HLVX strategic alternatives incoming
0 · Reply
WAYWARD_SUN
WAYWARD_SUN May. 19 at 2:41 PM
$HLVX
0 · Reply
joe77w
joe77w May. 8 at 1:19 PM
$HLVX 10Q out 3 usd in net equity https://www.otcmarkets.com/filing/html?id=18445085&guid=eeV-kFzAdOPedth
0 · Reply
PenkeTrading
PenkeTrading May. 1 at 12:48 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Hillevax Inc. Is that bullish or bearish? $HLVX #Hillevax #RsiOverbought #NASDAQ
0 · Reply
JarvisFlow
JarvisFlow Mar. 31 at 11:00 AM
HC Wainwright & Co. has updated their rating for HilleVax ( $HLVX ) to Neutral with a price target of 2.
0 · Reply
d_risk
d_risk Mar. 30 at 5:22 PM
$HLVX - HilleVax Inc. Common Stock - 10K - Updated Risk Factors HLVX's 2025 10-K Risk Factors highlight a strategic pivot from HIL-214 to broader norovirus vaccine candidates, emphasizing regulatory, patent, and commercialization challenges, workforce reductions, and increased reliance on third-party collaborations. New risks include potential Nasdaq delisting and geopolitical impacts on trade. #Biotechnology #GeopoliticalFactors #MarketCompetition #RegulatoryRisks #VaccineDevelopment 🟢 Added 🟠 Removed https://d-risk.ai/HLVX/10-K/2025-03-28
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 21 at 6:10 PM
$HLVX Tough break for HLVX. Norovirus vaccine miss is brutal. Might see some consolidation before potential pivot. Adult trial could be interesting play. Watching closely for strategic moves. solid article: https://beyondspx.com/article/hillevax-hlvx-navigating-the-challenges-of-norovirus-vaccine-development
0 · Reply
sivagnanam
sivagnanam Feb. 13 at 4:12 AM
$HLVX in
0 · Reply
TrendSetter67
TrendSetter67 Jan. 4 at 9:55 PM
$VXRT After reading this publication on enterics, how can $MRNA believe they will perform well with their Norovirus vaccine? They are on the same failed track as $HLVX. You can't protect against an intestinal virus with a needle in the arm. Oral/pill directly into the gut is the WAY. 💊 https://pmc.ncbi.nlm.nih.gov/articles/PMC9257994/
0 · Reply
Suh420
Suh420 Jan. 3 at 1:46 AM
$HLVX at Massive Key Breakout Level right now! $NIRO $QNCCF
0 · Reply
TrendSetter67
TrendSetter67 Jan. 2 at 5:53 PM
$VXRT Lesson to be learned... Pill/GALT vs Jab/Intramuscular. You can't protect against a disease of the gut (Enteric) with a needle in the arm. Mucosal protection via intestinal Peyer's Patches vaccine uptake is the Way. $HLVX only achieved 5% field efficacy. Are the $MRNA fans listening? Do you know your IgA measurements? Only Vaxart have worked out the true Norovirus Correlates of Protection.
2 · Reply
Tumble51
Tumble51 Dec. 23 at 12:02 AM
$WHWK $HLVX $LOGC $QURE Anyone that sells QURE, is a smart investor, their ceo sucks.
0 · Reply
jackcoltrain
jackcoltrain Dec. 21 at 1:18 AM
$QURE nice 171% gain since I rotated some $LOGC to this stock. I'm planning to sell some QURE to buy $HLVX. Missed out on $WHWK unfortunately
0 · Reply
TI7812
TI7812 Dec. 21 at 12:54 AM
$HLVX what could happen 2025 from their 3Q24 cash $189.3M marketable securities $303M a) liquidation of the company and return money to shareholders. Execs then have no income and have to find a job - https://x.com/Lord_of_Biotech/status/1815710509586342315 b) they buy some private biotech or a public biotech and execs get back on the biotech shitco gravy train. Maybe Tang "sells" them something he owns fully or partially to get access to that $500 million sitting in banks and burn through that too long small spec amount bought today to see what happens in 2025. small enough that I'll just ignore it.
1 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 11 at 2:28 PM
$HLVX HilleVax (HLVX): Navigating the Evolving Norovirus Vaccine Landscape https://beyondspx.com/article/hillevax-hlvx-navigating-the-evolving-norovirus-vaccine-landscape
0 · Reply
Kouradct
Kouradct Dec. 9 at 6:57 PM
$HLVX
0 · Reply
OpenOutcrier
OpenOutcrier Dec. 6 at 1:29 PM
$HLVX (+12.3% pre) HilleVax Shares Rise After Announcing Job Cuts, Executive Departures - MW https://ooc.bz/l/49951
0 · Reply
briefingcom
briefingcom Dec. 6 at 12:55 PM
Gapping up: $ASAN +26.5% $RBRK +20.9% $HLVX +16% $AOUT +14.6%
0 · Reply
SaudiWhale
SaudiWhale Dec. 6 at 1:49 AM
$HLVX break2.45 then the sky is limit ✅
0 · Reply
CheetahStock
CheetahStock Dec. 5 at 9:30 PM
$HLVX anyone know why it’s moving? Thanks
1 · Reply
approved_13
approved_13 Dec. 5 at 9:27 PM
$HLVX here we gooooooo
0 · Reply
TrendSetter67
TrendSetter67 Dec. 5 at 5:33 PM
$VXRT Things could be worse...we are trying to do a lower cost P2b/3 Noro trials, where FDA is not yet playing ball with us re: mucosal CoPs agreement. At least we are not $HLVX , that is sitting on a failed vaccine and trading at 1/2 cash as a zombie company who has had significant layoffs this year. Although they were talented in scamming funds to buy large shares in a cash raise all while executives were selling within 6-8 months of the public release of the 5% efficacy trial failure.
2 · Reply